**Patient Discharge Summary**

**Patient Information:**

* Name: Jane Doe
* Date of Birth: March 12, 1995
* Admission Date: March 10, 2023
* Discharge Date: March 20, 2023

**Medical History:**

Jane Doe, a 28-year-old female, was admitted to the endocrinology unit on March 10, 2023, with symptoms of increased thirst, frequent urination, and unintended weight loss over the past three months. She reported a family history of type 1 diabetes and had been experiencing significant fatigue and blurred vision.

**Admission Diagnosis and Workup:**

Upon admission, Jane Doe was diagnosed with type 1 diabetes based on her symptoms, medical history, and laboratory results. Her fasting plasma glucose (FPG) level was 320 mg/dL (17.8 mmol/L), and her glycosylated hemoglobin (HbA1C) level was 12.2%. She underwent an oral glucose tolerance test (OGTT), which confirmed the diagnosis of type 1 diabetes.

**Treatment and Management:**

Jane Doe was started on basal-bolus insulin therapy, consisting of 10 units of insulin glargine (Lantus) at bedtime and 5 units of insulin lispro (Humalog) before each meal. She was also prescribed metformin 500 mg twice daily as an adjunctive therapy.

**Medications:**

* Insulin glargine (Lantus): 10 units at bedtime
* Insulin lispro (Humalog): 5 units before each meal
* Metformin: 500 mg twice daily

**Dietary Recommendations:**

Jane Doe was advised to follow a balanced diet that focuses on whole foods, high-quality carbohydrates, and moderate protein intake. She was also encouraged to monitor her carbohydrate intake and adjust her insulin dosages accordingly.

**Exercise Recommendations:**

Jane Doe was recommended to engage in physical activity of at least 150 minutes per week, with a focus on aerobic exercises such as brisk walking, cycling, or swimming. She was also advised to adjust her insulin dosages and carbohydrate intake based on her exercise schedule.

**Education:**

Jane Doe received extensive education on diabetes management, including information on the causes of diabetes, symptoms and signs of hypoglycemia and hyperglycemia, and diabetic complications. She was also taught how to monitor her blood glucose levels, adjust her insulin dosages, and manage hypoglycemia.

**Follow-up Care:**

Jane Doe will follow up with her primary care physician in two weeks for a routine check-up and to adjust her medication regimen as needed. She will also receive regular foot examinations and funduscopic examinations to monitor for diabetic complications.

**Discharge Instructions:**

Jane Doe was discharged from the hospital on March 20, 2023, with the following instructions:

* Monitor her blood glucose levels at least four times a day
* Adjust her insulin dosages based on her blood glucose levels
* Follow a balanced diet and monitor her carbohydrate intake
* Engage in physical activity of at least 150 minutes per week
* Attend regular follow-up appointments with her primary care physician

**Conclusion:**

Jane Doe was diagnosed with type 1 diabetes and received comprehensive treatment and management. She was educated on diabetes management, and her treatment regimen was tailored to her individual needs. She will require regular follow-up care to monitor for diabetic complications and adjust her medication regimen as needed.